Clinical data
Trade names Tebron
ATC code None
CAS Number 679-84-5
PubChem (CID) 69623
ChemSpider 62826
Chemical and physical data
Formula C3H3BrF4
Molar mass 194.954 g/mol
3D model (Jmol) Interactive image

Halopropane (synonym FHD-3, trade name Tebron) is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed.[1] Its clinical development was terminated due to a high incidence of cardiac arrhythmias in patients, similarly to the cases of teflurane and norflurane.[2][3][4]

See also


  1. Nigel R. Webster; Helen F. Galley (22 August 2013). Landmark Papers in Anaesthesia. OUP Oxford. pp. 70–. ISBN 978-0-19-163319-5.
  2. Acta anaesthesiologica Belgica. Acta Medica Belgica. 1974.
  3. Sanford L. Klein (1993). A glossary of anesthesia and related terminology. Springer-Verlag. ISBN 978-0-387-97831-4.
  4. Earl J. Catcott; J. F. Smithcors (1973). Progress in canine practice. American Veterinary Publications.

This article is issued from Wikipedia - version of the 10/11/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.